Natco Pharma848.80
+11.20 (+1.34%)

Natco Pharma Share Price

848.80+11.20 (+1.34%)
-0.78% past 1 Year

Corporate filings & documents

Announcements

Natco Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/09/2026 inter alia to consider and approve to consider discuss and decide various matters in connection with the Rights Issue including the specific terms of the Rights Issue such as the determination of the Rights Issue price and related payment mechanism rights entitlement ratio the record date and timing of the Rights Issue
2 days ago
Natco Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/09/2026 inter alia to consider and approve to consider discuss and decide various matters in connection with the Rights Issue including the specific terms of the Rights Issue such as the determination of the Rights Issue price and related payment mechanism rights entitlement ratio the record date and timing of the Rights Issue
2 days ago
Receipt of In-principal approval for Rights Issue of Equity Shares
3 days ago
Receipt of In-principal approval for Rights Issue of Equity Shares
3 days ago
Draft letter of Offer
2 weeks ago
Draft letter of Offer
2 weeks ago
Outcome of Board Meeting
2 weeks ago
Outcome of Board Meeting
2 weeks ago
News Paper Publication
2 weeks ago
News Paper Publication
2 weeks ago
Notice of 43rd Annual General Meeting of the Company scheduled to be held on Wednesday the September 30 2026 at 11:00 AM (IST)
2 weeks ago
Notice of 43rd Annual General Meeting of the Company scheduled to be held on Wednesday the September 30 2026 at 11:00 AM (IST)
2 weeks ago
Business Responsibility and Sustainability Report
2 weeks ago
Business Responsibility and Sustainability Report
2 weeks ago
Annual Report for the FY 2025-26
2 weeks ago
Annual Report for the FY 2025-26
2 weeks ago
Natco Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/09/2026 inter alia to consider and approve Fund Raising
2 weeks ago
Natco Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/09/2026 inter alia to consider and approve Fund Raising
2 weeks ago
Investor Meet
3 weeks ago
Investor Meet
3 weeks ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Durga Devi Nannapaneni
4 weeks ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Durga Devi Nannapaneni
4 weeks ago
Press Release & Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015 regarding the investment in eGenesis Inc.
1 month ago
Press Release & Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015 regarding the investment in eGenesis Inc.
1 month ago
Intimation of Investor Meet
1 month ago
Intimation of Investor Meet
1 month ago
Conclusion of US FDS Inspection at our Visakhapatnam Andhra Pradesh Finished Dosage (FDF) Unit
1 month ago
Conclusion of US FDS Inspection at our Visakhapatnam Andhra Pradesh Finished Dosage (FDF) Unit
1 month ago
Investor Meet
1 month ago
Investor Meet
1 month ago
Investor Presentation
1 month ago
Investor Presentation
1 month ago
Q1FY2026-27 Transcript for the Earnings call held on 14th August 2026
1 month ago
Q1FY2026-27 Transcript for the Earnings call held on 14th August 2026
1 month ago
Intimation of Investors meeting organised by Nuvama Wealth Management Limited and ICICI Securities Limited
1 month ago
Intimation of Investors meeting organised by Nuvama Wealth Management Limited and ICICI Securities Limited
1 month ago
Newspaper Publication for the Un-Audited Financial Results for the quarter ended June 30 2026 and declaration of Interim Dividend for the FY ending 2026-27.
1 month ago
Newspaper Publication for the Un-Audited Financial Results for the quarter ended June 30 2026 and declaration of Interim Dividend for the FY ending 2026-27.
1 month ago
Weblink of Audio Transcript for the earnings call held on 14th August 2026 for Q1FY2026-27
1 month ago
Weblink of Audio Transcript for the earnings call held on 14th August 2026 for Q1FY2026-27
1 month ago
Investor Presentation for the Q1FY27
1 month ago
Investor Presentation for the Q1FY27
1 month ago
Board of Directors at their Meeting held on today i.e. 14th August 2026 had declared Interim Dividend of Rs.1.50 (75%) for face value of Rs.2/- each
1 month ago
Board of Directors at their Meeting held on today i.e. 14th August 2026 had declared Interim Dividend of Rs.1.50 (75%) for face value of Rs.2/- each
1 month ago
Outcome of Board Meeting
1 month ago
Outcome of Board Meeting
1 month ago
The Company will host an Earnings Call with Investors / Analysts on Friday the 14th August 2026 at 17:30 PM IST to discuss the Un-audited Financial Results of the Company for the quarter ended 30th June 2026
1 month ago
The Company will host an Earnings Call with Investors / Analysts on Friday the 14th August 2026 at 17:30 PM IST to discuss the Un-audited Financial Results of the Company for the quarter ended 30th June 2026
1 month ago
Natco Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Further to our earlier intimation dated August 6 2026 pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended this is to inform you that a meeting of the Board of Directors of the Company will be held on August 14 2026 to consider and evaluate proposals for raising funds through issuance of equity shares or other securities including by way of a public issue preferential issue rights issue private placement(s) qualified institutions placement(s) and/or any combination thereof or any other method as may be permitted in accordance with provisions of applicable laws subject to market conditions and receipt of regulatory statutory and other approvals as may be required
1 month ago
Natco Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Further to our earlier intimation dated August 6 2026 pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended this is to inform you that a meeting of the Board of Directors of the Company will be held on August 14 2026 to consider and evaluate proposals for raising funds through issuance of equity shares or other securities including by way of a public issue preferential issue rights issue private placement(s) qualified institutions placement(s) and/or any combination thereof or any other method as may be permitted in accordance with provisions of applicable laws subject to market conditions and receipt of regulatory statutory and other approvals as may be required
1 month ago

Concalls & investor presentations

Aug 2025
ConcallPresentation
Aug 2025
May 2025
Feb 2025
ConcallPresentation
Feb 2025
Nov 2024
ConcallPresentation
Nov 2024
Aug 2024
ConcallPresentation
Aug 2024
May 2024
ConcallPresentation
May 2024
Feb 2024
ConcallPresentation
Feb 2024
Nov 2023
ConcallPresentation
Nov 2023
Aug 2023
ConcallPresentation
Aug 2023
May 2023
ConcallPresentation
May 2023
Feb 2023
ConcallPresentation
Feb 2023
Nov 2022
ConcallPresentation
Nov 2022
Aug 2022
ConcallPresentation
Aug 2022
May 2022
ConcallPresentation
May 2022
Feb 2022
ConcallPresentation
Feb 2022
Nov 2021
ConcallPresentation
Nov 2021
Jun 2021
ConcallPresentation
Jun 2021
Feb 2021
ConcallPresentation
Feb 2021
Nov 2020
ConcallPresentation
Nov 2020

Natco Pharma Ltd Share Price Today

The Natco Pharma Ltd share price today is ₹837.00. During the trading session, the Natco Pharma Ltd share price opened at ₹829.00 and recorded an intraday high of ₹841.50 and a low of ₹828.00. Last closing price was ₹828.65. Over the past 52 weeks, the Natco Pharma Ltd share price has ranged between ₹789.00 and ₹1226.80. The current Natco Pharma Ltd stock price reflects real-time market activity based on executed trades on the exchange.